ArticleClinical case reports2018
Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma.
Juan Pablo Alderuccio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it